Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model

New therapeutic strategies are required for critical size bone defects, because the gold standard of transplanting autologous bone from an unharmed area of the body often leads to several severe side effects and disadvantages for the patient. For years, tissue engineering approaches have been seekin...

Descripción completa

Detalles Bibliográficos
Autores principales: Boos, Anja M, Weigand, Annika, Deschler, Gloria, Gerber, Thomas, Arkudas, Andreas, Kneser, Ulrich, Horch, Raymund E, Beier, Justus P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242408/
https://www.ncbi.nlm.nih.gov/pubmed/25429218
http://dx.doi.org/10.2147/IJN.S66867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242408/
https://www.ncbi.nlm.nih.gov/pubmed/25429218
http://dx.doi.org/10.2147/IJN.S66867

Ejemplares similares